Comparison of the efficacy of topical methotrexate 1% gel versus topical betamethasone dipropionate 0.05% lotion in the treatment of localized scalp alopecia areata in a tertiary care institute of Central India: A Randomized control trial

Susmita Banra0 个研究点目标入组 70 人开始时间: 待定最近更新: 2023年10月16日

试验速览

暂无简介。

•1.Age of patients greater than 12 years with localized alopecia areata over scalp.
•2.Presence of five or fewer patches of alopecia areata, involving less than 50% scalp area

•1.Patients who have received topical or oral treatment for alopecia areata in the past 1 month.
•2.Alopecia areata over areas other than scalp.
•3.Presence of ophiasis, diffuse alopecia areata, alopecia totalis and alopecia universalis patients.
•4.Other coexisting hair disorder diagnosed based on clinical history and examination (trichotillomania, androgenetic alopecia, telogen effluvium, tinea capitis)
•5.Pregnancy
•6.Presence of any contraindication or allergy for topical corticosteroids or topical methotrexate.
•7.Patient having steroid induced side effects like atrophy, telangiectasia etc.
•8.Patients who are not willing to participate.

发起方

Susmita Banra